Want to see DOC full AI Analyst Report?
DOC Stock Chart & Stats
$17.37
$0.33(1.66%)
At close: 4:00 PM EST
$17.37
$0.33(1.66%)
Day’s Range― - ―
52-Week Range$15.70 - $22.72
Previous CloseN/A
Volume1.14M
Average Volume (3M)6.50M
Market Cap
$15.75B
Enterprise Value$22.10K
Total Cash (Recent Filing)$1.17B
Total Debt (Recent Filing)$10.71B
Price to Earnings (P/E)70.7
Beta0.48
Next Earnings
Aug 04, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield5.4%
Share Statistics
EPS (TTM)0.32
Shares Outstanding689,419,700
10 Day Avg. Volume5,766,884
30 Day Avg. Volume6,500,969
Financial Highlights & Ratios
PEG Ratio-2.23
Price to Book (P/B)1.49
Price to Sales (P/S)3.97
P/FCF Ratio8.94
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$21.96Price Target Upside26.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)0.33
Revenue Forecast (FY)$2.96B
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained operating and free cash flow (TTM > $1.1B) provides a durable funding base for dividends, development, accretive acquisitions and buybacks. Strong cash conversion reduces reliance on volatile capital markets and supports the REIT's capacity to recycle capital and underwrite long-duration leases.
Outpatient Portfolio StrengthHigh occupancy, strong tenant retention and positive re-leasing spreads in outpatient medical space underpin stable, predictable NOI. Lower leasing costs and in‑house renewals improve margin sustainability, making outpatient assets a resilient earnings engine amid secular shifts toward outpatient care.
Strategic Brookfield JVThe Brookfield partnership monetizes a large outpatient portfolio while preserving operational control and upside participation. It provides material non-dilutive liquidity for deployments or deleveraging, and establishes a long-term capital program that structurally improves funding flexibility and balance sheet optionality.
Bears Say
Elevated LeverageMeaningful leverage limits financial flexibility and amplifies sensitivity to interest-rate movements. High net leverage constrains the firm's ability to pursue opportunistic acquisitions or absorb prolonged leasing softness without asset sales, and reduces the buffer for dividend and FFO stability during downturns.
Life Science Vacancy & Spread PressureBelow‑market occupancy and softer lab re-leasing spreads signal persistent submarket and demand imbalances. Given life science's capital intensity and underwriting, sustained vacancy or weaker spreads will pressure NOI and require successful conversion of the leasing pipeline to realize forecasted earnings growth.
Refinancing And Interest HeadwindsNear-term maturities and higher projected interest expense increase funding cost risk and may reduce FFO and distributable cash. In a higher-rate environment, refinancing at wider spreads could necessitate asset recycling or slow growth initiatives, pressuring capital allocation plans and long-term return targets.
DOC FAQ
What was Healthpeak Properties’s price range in the past 12 months?
Healthpeak Properties lowest stock price was $15.70 and its highest was $22.72 in the past 12 months.
What is Healthpeak Properties’s market cap?
Healthpeak Properties’s market cap is $15.75B.
When is Healthpeak Properties’s upcoming earnings report date?
Healthpeak Properties’s upcoming earnings report date is Aug 04, 2026 which is in 13 days.
How were Healthpeak Properties’s earnings last quarter?
Healthpeak Properties released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.053 by $0.227.
Is Healthpeak Properties overvalued?
According to Wall Street analysts Healthpeak Properties’s price is currently Undervalued.
Does Healthpeak Properties pay dividends?
Healthpeak Properties pays a Monthly dividend of $0.102 which represents an annual dividend yield of 5.4%. See more information on Healthpeak Properties dividends here
What is Healthpeak Properties’s EPS estimate?
Healthpeak Properties’s EPS estimate is 0.03.
How many shares outstanding does Healthpeak Properties have?
Healthpeak Properties has 689,419,700 shares outstanding.
What happened to Healthpeak Properties’s price movement after its last earnings report?
Healthpeak Properties reported an EPS of $0.28 in its last earnings report, beating expectations of $0.053. Following the earnings report the stock price went up 18.115%.
Which hedge fund is a major shareholder of Healthpeak Properties?
Currently, no hedge funds are holding shares in DOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthpeak Properties Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.96 (26.43% Upside)
$21.96 (26.43% Upside)
Blogger Sentiment
Bullish
DOC Sentiment 70%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 221.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $213.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.17%
12-Months-Change
Fundamentals
Return on Equity
5.40%
Trailing 12-Months
Asset Growth
9.09%
Trailing 12-Months
Company Description
Healthpeak Properties
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
DOC Revenue Breakdown
76.41% Rental and related revenues
21.40% Resident fees and services
2.19% Interest income and other

DOC Stock 12 Month Forecast
Average Price Target
$21.96
▲(26.43% Upside)
Technical Analysis
National Health Investors
―
Omega Healthcare
―
Sabra Healthcare REIT
―
―
Healthcare Realty Trust
―
Ownership Overview
0.24% Insiders
29.11% Mutual Funds
0.55% Other Institutional Investors
35.68% Public Companies and
Individual Investors









